|
|
| Line 52: |
Line 52: |
| **[[3my0]] - hALK1 kinase domain + inhibitor<br /> | | **[[3my0]] - hALK1 kinase domain + inhibitor<br /> |
|
| |
|
| *Activin receptor-like kinase 5 or Serine/threonine-protein kinase receptor R4 or ALK5 or TGF-beta receptor type 1 or TGFR-1 or SKR4
| |
|
| |
| **[[5e8s]], [[1ias]] - hALK5 kinase domain<br />
| |
| **[[5e8u]], [[5e8t]] - hALK5 kinase domain (mutant)<br />
| |
| **[[2l5s]] - hALK5 LBD - NMR<br />
| |
| **[[3kfd]] - hALK5 LBD + TGFR-2 LBD + TGF-beta-1<br />
| |
| **[[2pjy]] - hALK5 LBD + TGFR-2 LBD + TGF-beta-3<br />
| |
| **[[2wot]], [[2wou]], [[3hmm]], [[5usq]], [[3gxl]], [[5fri]], [[3tzm]], [[1vjy]], [[4x0m]], [[4x2f]], [[4x2g]], [[4x2j]], [[4x2k]], [[4x2n]], [[2x7o]], [[3faa]], [[3kcf]], [[1py5]], [[1rw8]] - hALK5 kinase domain + inhibitor<br />
| |
| **[[5e90]], [[5e91]], [[5qil]], [[5qik]], [[5qim]], [[6b8y]], [[5qu0]], [[5qtz]], [[5e8z]] - hALK5 kinase domain (mutant) + inhibitor<br />
| |
| **[[5e8x]], [[5e8w]] - hALK5 kinase domain (mutant) + staurosporine<br />
| |
| **[[5e92]] - hALK5 kinase domain (mutant) + AMPPNP<br />
| |
| **[[1b6c]] - hALK5 kinase domain + FKBP12<br />
| |
|
| |
| *TGF-beta receptor type 2 or TGFR-2
| |
|
| |
| **[[1m9z]] - hTGFR-2 LBD<br />
| |
|
| |
| *TGF-beta receptor type 3 or TGFR-3
| |
|
| |
| **[[4ajv]] - mTGFR-3 ZP-C domain 591-757<br />
| |
| **[[3qw9]] - rTGFR-3 ZP-C domain<br />
| |
| }} | | }} |
|
| |
|
| == References == | | == References == |
| <references/> | | <references/> |